#USA #New York #Securities Fraud #Rosen Law Firm #Boston Scientific

Boston Scientific Investors Encouraged to Participate in Class Action Lawsuit

Investors who purchased common stock of Boston Scientific Corporation (NYSE: BSX) between July 23, 2025, and February 3, 2026, are being invited to take part in a class action lawsuit initiated by the Rosen Law Firm, an internationally recognized firm specializing in investor rights. This lawsuit focuses on allegations of securities fraud and misrepresentation pertaining to the company's operations within its U.S. Electrophysiology segment.

Why This Lawsuit Matters

During the mentioned period, Boston Scientific allegedly provided investors with overly optimistic statements about its financial health while obscuring crucial information regarding the sustainability of its growth rates. Specifically, internal insights suggested that the growth in the Electrophysiology segment was on a decline, contrary to the public assurances provided by company management. Consequently, when these realities became public, investors faced significant financial repercussions due to an unexpected miss in the company's net income and subdued guidance for the first half of 2026.

As headlines erupted, the market's reaction revealed that loyal investors were left in a state of shock, suffering losses that could have been mitigated had they been privy to the accurate state of the company's performance.

Steps for Investors to Take

If you have bought Boston Scientific's shares during the specified time frame, you might be eligible for compensation without incurring any out-of-pocket costs thanks to a contingency fee agreement. Interested parties should act swiftly, as the deadline for appointing a lead plaintiff is set for May 4, 2026. This lead plaintiff will play an essential role, representing all members of the class in guiding the litigation.

To join the class action, investors can take the following steps:
1. Visit the Rosen Law Firm’s official submission page.
2. Call Phillip Kim, Esq. at 866-767-3653 for further assistance.
3. Email inquiries can be sent to [email protected] for additional information.

The firm aims to empower investors by providing representation from seasoned attorneys with notable success in similar cases, boasting of substantial recoveries for their clients in the past.

The Reputation of Rosen Law Firm

The Rosen Law Firm has established a prominent position within the investment community, noted for achieving the largest securities class action settlement against a Chinese entity. The firm's accolades further include being ranked first by ISS Securities Class Action Services for the number of successful settlements in 2017, securing hundreds of millions of dollars for investors year after year. Such recognition highlights the firm's competence and commitment to safeguarding the interests of shareholders.

Noteworthy Considerations

It is crucial to note that currently, no class has been officially certified. Investors have the autonomy to either select their counsel or remain an absent class member without immediate action. It is important to highlight that eligibility to benefit from any future recoveries is not contingent on taking on the role of lead plaintiff.

In conclusion, if you are a Boston Scientific investor who may have been adversely affected, now is the time to explore your options. Engaging in this class action lawsuit not only provides a path to potential compensation but also sends a strong message that accountability in corporate governance is paramount. For ongoing updates and information, investors are encouraged to follow the Rosen Law Firm's social media channels on LinkedIn, Twitter, and Facebook.

• ---

Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll-Free: (866) 767-3653
Email: [email protected]
Website: www.rosenlegal.com